Joshua Zeidner and Curtis Lachowiez
Dec 10, 2024, 18:55
Joshua Zeidner: The prognostic influence of monocytic phenotypes in patients treated with Azacitidine and Venetoclax
Joshua Zeidner, Associate Professor at UNC Lineberger, shared on X:
“Fantastic presentation by Curtis Lachowiez showing the significant prognostic influence of monocytic phenotypes in pts treated with Aza/Ven. In NPM1 wt, monocytic phenotypes led to significantly worse outcomes. Differentiation state should be incorporated into our risk scores.”
Curtis Lachowiez, Assistant Professor of Medicine at Oregon Health and Science University, shared this post, adding:
“Thank you Joshua Zeidner and Daniel Pollyea for the collaboration on this project. Excited for more to come!”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 10, 2024, 18:50
Dec 10, 2024, 18:37
Dec 10, 2024, 18:36
Dec 10, 2024, 18:34
Dec 10, 2024, 18:29
Dec 10, 2024, 18:02